Twist Bioscience's P/S ratio remains lower due to sub-par re...
Twist Bioscience's P/S ratio remains lower due to sub-par revenue outlook, indicating investor expectation of limited future growth. Shareholder pessimism around future revenue growth contributes to this lower ratio.
Twist Bioscience Corporation (NASDAQ:TWST) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment